baber/WOPTO huggingface dataset:
Patent NZ-243795-A (NZ)
Title: 2-carbonylamino-1-sulphonyl indoline derivatives, preparatory processes and pharmaceutical compositions
Inventor: WAGNON JEAN
IPC: C07D295/192
Filed: 1992-07-31
Abstract: 3-Hydroxy-1-indolinyl sulphones of formula (I) and their salts are new: In (I), R1 = halogen, 1-4C alkyl, OH, 1-4C alkoxy, benzyloxy, CN, CF3, NO2 or NH2; R2 = 1-6C alkyl; 3-7C cycloalkyl,; 5-7C cycloalkenyl; phenyl opt. substd. by 1-4C alkyl, 1-4C alkoxy, halogen, CF3 and/or NH2; or nitrophenyl opt. substd. by CF3, 1-4C alkyl or halogen; R5 = 1-4C alkyl; 1- or 2-naphthyl;5-dimethylamino-1-naphthyl; phenyl opt. substd. by halogen, CF3, NH2, mono- or di (1-4C alkyl) amino, OH, 1-4C alkoxy, 2-4C alkenyloxy, 1-4C alkylthio, CF3, benzyloxy, CN, COOH, 2-5C alkoxycarbonyl, CONH2, mono- or di (1-4C alkyl)carbamoyl or 1-4C alkanoylamino; or nitrophenyl opt. substd. by CF3, 2-4C alkenyloxy, halogen, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylthio, OCF3 or benzyloxy; R6 = 1-6C alkyl or R7; R7 = 1-R-4-piperidinyl, 1-R-3-azetidinyl or (CH2)rR'; R = H, 1-4C alkyl, benzyloxycarbonyl or 2-5C alkoxycarbonyl; R1 = pyridyl, OH, NH2, mono- or di(1-4C alkyl)amino, COOH, 2-5C alkoxycarbonyl, benzylcarbonyl, CONH2 or mono- or di(1-4C alkyl)carbamoyl; or NR6R7 = morpholino; thiomorpholino; thiazolidinyl or 2,2-dimethylthiazolidinyl opt. substd. by R8; 1-piperazinyl opt. 4-substd. by R"8; and unsatd. 5-membered monoaza ring substd. by R8; or a satd. 3- to 7-membered monoaza ring substd. by R8 and R9; R8 = R'8 or (CH2)rA1, where A1 = OH, NH2 or mono- or di(1-4C alkyl)amino; R'8 = (CH2)qA2, where A2 = COOH, 2-5C alkoxycarbonyl, benzyloxycarbonyl, CONH2, CONHOH, mono- or di(1-4C alkyl)carbamoyl, CSNH2 or mono- or di(1-4C alkyl)thiocarbamoyl; R"8 = R8' or (CH2)A3, where A3 = NH2 or mono- or di(1-4C alkyl)amino; R9 = H, halogen, (CH2rOR10), (CH2)rNR11R12, (CH2)SCONR11R'11 or N3; R10 = H, 1-4C alkyl, mesyl or tosyl; R11, R'11 and R12 = H or 1-4C alkyl, or R11 = H, and R12 = benzyloxycarbonyl or 2-5C alkoxycarbonyl; n and m = 0-2; q = 0-3; r = 0-3, but not 0 when R8 or R9 is in a position alpha to the intracyclic amidic nitrogen (SiC); s = 0 or 1.
Patent NZ-260299-A (NZ)
Title: 1h-indole-3-ylacetic acid hydrazide derivatives and pharmaceutical compositions
Inventor: BACH NICHOLAS JAMES
IPC: C07D209/24
Filed: 1994-04-13
Abstract: A class of 1H-indole-3-acetic acid hydrazides, represented by the formula (I) <CHEM> is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock.
Patent NZ-293533-A (NZ)
Title: Shelving system
Inventor: LEAHY JOHN
IPC: A47B57/58
Filed: 1996-10-17
Abstract: PCT No. PCT/AU96/00654 Sec. 371 Date Apr. 10, 1998 Sec. 102(e) Date Apr. 10, 1998 PCT Filed Oct. 17, 1996 PCT Pub. No. WO97/14334 PCT Pub. Date Apr. 24, 1997A shelving system including: (a) a frame (18); (b) the frame having a rear member (22), a front member (24) spaced from the rear member (22), and at least one side (20) joining the front member (24) and the rear member (22); (c) the rear member (22) having a rear attachment portion (36), the rear attachment portion (36) having a front face (60) with a plurality of grooves (62) therein; (d) the front member (24) having a front attachment portion (38), the from attachment portion (38) having a rear face (48) with a plurality of grooves (50) therein; (e) at least one product support (30, 32, 34) extending between and being supported by the rear member (22) and the front member (24); (f) the product support (30, 32, 34) having at least one fin (78, 80) depending therefrom to engage in at least one of the grooves (50, 62) of the front attachment portion (38) and rear attachment portion (36).
Patent NZ-328135-A (NZ)
Title: Absorbent article comprising two regions of differing extensibility
Inventor: OSBORN THOMAS WARD
IPC: A61F13/15
Filed: 1992-10-30
Abstract: The present invention relates to absorbent articles such as sanitary napkins worn by women. More particularly, the present invention relates to absorbent articles, such as thin sanitary napkins, that are stretchable, especially in the longitudinal direction.
Patent NZ-331489-A (NZ)
Title: Genotype determination of collagen gene col 1 for diagnosis of osteoporosis or predisposition to osteoporosis
Inventor: RALSTON STUART HAMILTON
IPC: C12Q1/6883
Filed: 1997-02-28
Abstract: Diagnostic means that determines the genotype of a collagen gene of an individual is described. A polymorphism in the collagen gene correlates with predisposition to osteoporosis, so diagnosis of a predisposition is achieved using the diagnostic means. An isolated gene comprising the nucleotide substitution of the polymorphism is also described, as is a method of diagnosis based on the presence or absence of the polymorphism.
Patent NZ-333518-A (NZ)
Title: Immunological assay for spongiform encephalopathies (TSE)
Inventor: O'CONNOR MICHAEL
IPC: C07K14/47
Filed: 1998-02-06
Abstract: A method for detecting the putative agent for TSE in animals selected from cattle, sheep and pigs, comprises taking a body tissue sample from the carcass of the animal, reacting the sample in a immunological assay with a labelled prion specific antibody and determining the amount of labelled antibody bound to the sample. The antibody for use in the method is selected from antibodies raised against one or more of the following sequences: MVKSHIGSWILVLFVVAMWSDVGLCKKRPKPGGGWNTGGSRYPGO-44 GSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGQGQP-87 GGGGWGQGGSHSQWNKPSKPPKTNMKHVAGAAAGAVVGGLGGY-131 MLGSAMSSPLIHFGNDYEDRYTRENMYRYPNQVYYRPVDRYSNQNN-177
Patent NZ-337105-A (NZ)
Title: Plant pyruvate dehydrogenase kinase gene and transgenic plants
Inventor: ZOU JITAO
IPC: C12N9/12
Filed: 1998-02-09
Abstract: A mitochondrial pyruvate dehydrogenase kinase (PDHK) gene from Arabidopsis has been isolated, purified and characterized (pYA5; ATCC 209562 and pAsYA5; ATCC 209561).  Plants transformed with the sense or antisense PDHK gene may exhibit altered seed oil content, seed size/weight, flowering time, respiration rate, biopolymer content and resistance to cold temperature, as compared to a genomically unmodified plant of the same genotype.
Patent NZ-507787-A (NZ)
Title: Novel mutations in the FREAC3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
Inventor: WALTER MICHAEL A
IPC: C12Q1/68
Filed: 1999-04-16
Abstract: A method for diagnosing a mammal for an increased likelihood of developing a disease of the eye or having a developmental defect comprises analyzing a nucleic acid to determine whether it contains a mutation that encodes a mutant FREAC3 polypeptide. The presence of the mutation indicates that the mammal has an increased likelihood of developing a disease of the eye of having a developmental defect. Also described is a nucleic acid encoding a mutant FREAC3 polypeptide and a cultured cell containing the nucleic acid. A nucleic acid that encodes wild-type FREAC3 polypeptide can be used in the treatment of a disease of the eye.
Patent NZ-508139-A (NZ)
Title: Adaptive seismic noise and interference attenuation method
Inventor: OZBEK ALI
IPC: G01V1/36
Filed: 1999-05-18
Abstract: A method relating to filtering coherent noise and interference from seismic data by constrained adaptive beamforming is described using a constraint design methodology which allows the imposition of an arbitrary predesigned quiescent response on the beamformer. The method also makes sure that the beamformer response in selected regions of the frequency-wavenumber space is entirely controlled by this quiescent response, hence ensuring signal preservation and robustness to perturbations. Built-in regularization brings an additional degree of robustness. Seismic signals with arbitrary spectral content in the frequency-wavenumber domain are preserved, while coherent noise and interference that is temporally and spatially nonstationary is adaptively filtered. The approach is applicable to attenuation of all types of coherent noise in seismic data including swell-noise, bulge-wave noise, ground-roll, air wave, seismic vessel and rig interference, etc. It is applicable to both linear or areal arrays.
Patent NZ-515360-A (NZ)
Title: A tear-off device for opening drink cans
Inventor: CAVALLO VENCENZO
IPC: B65D/
Filed: 2000-03-28
Abstract: A tear-off opening device for drink cans has a tab (1) with a grip device (2) for tearing and a shaped lamina secured underneath the lid (6). The lamina is able to change from a first stable configuration in which it is drawn up underneath the tab (1) when the can is closed, through to a final stable configuration with the tab entirely pulled back, in which, with the extraction completed, the lamina constitutes a stable spout (8).
Patent NZ-517620-A (NZ)
Title: A conjugate comprising a non-peptide moiety, a linking unit and a cytostatic radical
Inventor: LERCHEN HANS-GEORG
IPC: C07K5/083
Filed: 2000-08-28
Abstract: A conjugate comprises a non-peptide moiety binding to aVb3 or aVb5 integrin (vitronectin) receptors, a linking unit, which can be cleaved enzymatically or hydrolytically with release of the cytotoxic radical or of the radical of a cytostatic or of a cytostatic derivative, and a cytostatic radical or a radical of a cytostatic or of a cytostatic derivative. Preferably the cytostatic radical is camptothecin or 9-aminocamptothecin. The conjugate can be used in the manufacture of a medicament for the treatment of carcinomatous disorders. Also described is process for preparing the conjugates.
Patent NZ-521563-A (NZ)
Title: Peptide conjugates for drug delivery
Inventor: CRISANTI ANDREA
IPC: A61K47/48
Filed: 2001-04-12
Abstract: An isolated peptide capable of translocation across a cell membrane, the peptide being conjugated via a covalent attachment to a therapeutic agent, wherein the peptide comprises the amino acid sequence KKX1X2K, where X1 is A or P and X2 is K or R, and wherein the agent has its site of therapeutic activity within a cell. Also covered is the use of said peptide in the manufacture of a composition to treat a disease.
Patent NZ-525219-A (NZ)
Title: Switchably decoupling resonant circuits utilised for controlling inductive power transfer from an alternating current source
Inventor: BOYS JOHN TALBOT
IPC: H02J5/00
Filed: 2003-04-09
Abstract: An inductive power receiver, either parallel resonant (Fig 1) or series resonant (Fig 2) at the frequency of the received power from the AC supply 11, 21, provides rectified power from rectifier 14, 24 and may be decoupled from the power supply by operation of a switch 51 or 62 in the decoupling and load circuits Fig 5 or Fig 6 connected across the output of the power receiver rectifier 14, 24. The switch is operated cyclically at a frequency that is not related to the power supply frequency. The theoretical lossless output voltage or the theoretical lossless output current are a function of the fractional time the switch is on divided by the fractional time the switch is off, i.e. D/(1-D) or (1-D)/D, where D is the fractional time that the switch is on in a switching cycle.
Patent NZ-525611-A (NZ)
Title: Plastic film for packaging three dimensional objects
IPC: C09J7/22
Filed: 2003-05-01
Abstract: The base film (2) is orientated polypropylene, preferably bi-axially orientated polypropylene or polyethylene terephthalate. To the metallized side (3), a printed layer (5) is applied. On the opposite side a cold adhesive (6) is applied sparingly, preferably in strip form.
Patent NZ-525664-A (NZ)
Title: Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
Inventor: ROBL JAMES M
IPC: C12N5/10
Filed: 2001-11-16
Abstract: A transgenic ungulate which comprises a genetic modification that results in inactivation and loss of expression of its endogenous antibodies, and the expression of xenogenous human antibodies. This is effected by inactivation of the IgM heavy chain expression and, optionally, by inactivation of the Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of human antibodies. Also disclosed are methods for producing antibodies using the transgenic ungulate.
Patent NZ-526148-A (NZ)
Title: Novel glyphosate N-acetyltransferase (GAT) genes
Inventor: CASTLE LINDA A
IPC: A01H5/00
Filed: 2001-10-29
Abstract: An isolated or recombinant polynucleotide encodes a polypeptide that has glycophosate N-acetyl transferase activity and preferably comprises a nucleotide sequence encoding an amino acid sequence consisting of SEQ. ID No.: 300, SEQ. ID No.: 445, or SEQ. ID. No.:457. Methods of producing the polypeptide, or a glyphosate resistant transgenic plant, seed or plant cell comprise (a) transforming a plant or plant cell with a polynucleotide encoding a glyphosate N-acetyltransferase and (b) optionally regenerating a transgenic plant from the transformed plant cell. Methods for selectively controlling weeds in a field containing a crop comprise: (a) planting the field with crop seeds or plants which are glyphosate-tolerant as a result of being transformed with a polynucleotide encoding a glyphosate N-acetyltransferase and (b) applying to the crop and weeds in the field a sufficient amount of glyphosate to control the weeds without significantly affecting the crop. Cells containing the polynucleotides and a transgenic plant, seed or transgenic plant explant that exhibits enhanced resistance to glyphosate as compared to a wild type plant of the same species, strain or cultivar are also described.
Patent NZ-526350-A (NZ)
Title: Anti-aging compositions comprising an amino acid, vitamin B complex, metal salt and an amino alcohol
Inventor: AL-SHAKARCHI A MUNEM MOHAMMAD
IPC: A61K33/24
Filed: 2003-06-09
Abstract: An anti-ageing composition suitable for administrating to warm blooded animals including: one or more mono, di and/or trivalent metal salts, one or more amino acids, an amino alcohol and a vitamin B complex. Preferably the amino alcohol is selected from diethyl amino ethanol and dimethyl amino ethanol, the metals salts are selected from potassium, copper, calcium, manganese, molybdenum, selenium, vanadium, zinc, chromium, vanadium, the amino acid is selected from glutamine, arginine, lysine, orthine, proline, and histidine and the vitamin B complex is selected from para amino bezoic aicd, B1 (thiamin), B2 (riboflavin), B3, B5, B6 (pyridoxine) and B12 (cobalamin). The composition can also further comprise components including L-Taurine, inositol, choline, heseperidine, an oligopeptide, resveratrol, folic acid, biotin, vitamin D, vitamin A, ginko biloba extract, lycopene, proanthocyanidin, black seed extract, bromelain, lipase, catalese, colloidal silica, iodine and an immuno-stimulant.
Patent NZ-529779-A (NZ)
Title: Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
Inventor: POPP MICHAEL A
IPC: A61P9/00
Filed: 2002-04-10
Abstract: Described is a pharmaceutical formulation consisting of a calcium salt and a plant dry extract and provided in the form of a coated tablet, whereby the formulation has a core comprised of at least one plant dry extract that is enclosed by at least one coating made of at least one calcium salt. The plant extracts used for the core can be selected among: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard flower); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (red clover); Oenothera biennis hom. (evening primrose); Glycine soja (soybean); Serenoa repens (saw palmetto); Urtica dioica (stinging nettle), particularly the roots thereof; Cucurbita pepo (pumpkin), particularly the seeds thereof; and Pygeum africanum; as well as suitable mixtures thereof.
Patent NZ-531666-A (NZ)
Title: PRO1555 polypeptides and sequences thereof with homology to transmembrane proteins
Inventor: BAKER KEVIN
IPC: C07K14/435
Filed: 1999-09-01
Abstract: An isolated nucleic acid having at least 80% sequence identity to a nucleotide sequence that encodes a polypeptide designated PRO1555 comprising the amino acid sequence SEQ ID NO:337 is described. Preferably the nucleic acid comprises the sequence of SEQ ID NO:338 or is that deposited under accession number ATCC 203322. Vectors, isolated host cells, processes for preparing the polypeptide, pharmaceutical compositions and antibodies are also described. (62) Divided out of 510464
Patent NZ-534396-A (NZ)
Title: Oligonucleotides comprising alternating segments of sugar-modified nucleosides and 2'-deoxynucleosides and uses thereof
Inventor: DAMHA MASAD J
IPC: A61K31/7088
Filed: 2003-01-31
Abstract: An oligonucleoside comprising alternating arabinonucleoside segments and 2'-deoxynucleoside segments wherein: i) the arabinonucleoside segments each independently consists of at least one arabinonucleoside; ii) the 2'-deoxynucleoside segments each independently consists of at least one deoxynucleoside; and iii) the oligonucleoside comprises at least four segments.
Patent NZ-535600-A (NZ)
Title: MASP-depleted MBL compositions are superior at activating the complement cascade when compared with MBL purified in complex with its associated MASPs
Inventor: O'BRIEN GRACE
IPC: A61P31/00
Filed: 2003-04-24
Abstract: Disclosed is a therapeutic composition comprising isolated non-recombinant mannose binding lectin (MBL) substantially free from activated MBL associated serine proteases (MASPs) together with a pharmaceutically acceptable carrier or diluent. Also disclosed is the above composition wherein the MBL is obtained by a method comprising: (i) providing a complex of non-recombinant MBL and one or more MASPs; (ii) incubating the complex in a suitable buffer to dissociate the MBL from the one or more MASPs; and (iii) separating the MBL from the one or more MASPs. Also disclosed is the use of the above composition for the treatment of a disease associated with a MBL deficiency.
Patent NZ-536193-A (NZ)
Title: Collagen and method for producing same
Inventor: SNOWDEN JOHN
IPC: A61L27/24
Filed: 2003-05-20
Abstract: Described is a method for producing collagen from a mammalian animal skin comprising applying to the skin an organic acid buffer and incubating the skin for a sufficient time to loosen attached wool or hair; mincing or chopping the skin to produce skin pieces; and extracting the collagen from the skin pieces. Disclosed are preferential time and temperature ranges of incubation, as well as effective pH ranges of the organic buffer.
Patent NZ-537830-A (NZ)
Title: Novel physiologically active substances
Inventor: KOTAKE YOSHIHIKO
IPC: C12P17/16
Filed: 2003-07-31
Abstract: Disclosed are 12-membered ring macrolide compounds represented by the formula (I). Due to their ability of inhibiting angiogenesis and inhibiting the production of VEGF particularly in hypoxia, the compounds are useful as remedies for solid cancer.
Patent NZ-539811-A (NZ)
Title: Solid-state polypeptide particles that facilitate the loading of an implant delivery system with a concentration of stabilised, therapeutic polypeptide sufficiently high to enable delivery of therapeutic doses of the polypeptide over an extended period of time
Inventor: BENTZ JOHANNA
IPC: A61K9/00
Filed: 2003-10-28
Abstract: Disclosed are stabilized polypeptide particles comprising a polypeptide selected from the pituitary adenylate cyclase polypeptide/glucagon superfamily and a stabilizing agent selected from disaccharides and monosaccharides that are stable under acidic conditions at temperatures up to or exceeding physiological conditions, the polypeptide particles being formulated to exhibit an acidic reconstitution pH.
Patent NZ-546404-A (NZ)
Title: Transgenic cells expressing nucleic acids encoding glucosyltransferase polypeptides
Inventor: BOWLES DIANNA
IPC: C12N9/10
Filed: 2004-10-12
Abstract: An isolated transgenic cell wherein said cell is transfected with a vector that comprises a nucleic acid molecule selected from the group consisting of: i) a nucleic acid molecule comprising a nucleic acid sequence as represented in Figure 1 and Figure 3 and/or Figure 5 which encodes a polypeptide that glucosylates at least one from the group consisting of p-coumaryl aldehyde, coniferyl aldehyde, sinapyl aldehyde and coniferyl alcohol; ii) a nucleic acid molecule comprising a nucleic acid sequence which hybridises to the sequence in (i) above and which encodes a polypeptide that glucosylates at least one from the group consisting of p-coumaryl aldehyde, coniferyl aldehyde, sinapyl aldehyde and coniferyl alcohol; wherein said cell expresses a nucleic acid molecule selected from the group consisting of i) and ii) above.
Patent NZ-547729-A (NZ)
Title: Method for milking animals
Inventor: KAEVER PETER
Filed: 2006-06-07
Abstract: A method for milking animals in which more than one animal are simultaneously milked in a milking parlour, comprises a holding time at a milking parlour for a single animal being dependent on the holding time of other animals to be milked simultaneously with said animal that is to be milked. The animals receive a quantity of feed during the milking process, and the quantity of feed given to the individual animal is determined in dependence on the holding times of the animals milked simultaneously in the milking parlour.
Patent NZ-548891-A (NZ)
Title: Injection device
Inventor: STAMP KEVIN
IPC: A61M5/24
Filed: 2005-01-24
Abstract: An injection device comprising an outer housing inside which is located a medicament-holding barrel (9) with a needle (10) at one end thereof, at least part of the needle being moveable in and out of the outer housing, a plunger (8) moveable within the barrel, an inner housing (7) intermediate the outer housing (6) and the barrel and plunger and an energy source (1) in communication with the inner housing. The inner housing is moveable by the energy source between a first position in which the inner housing has one or more radially flexible tags (7B) which are in communication with the barrel such that, in use, the plunger and barrel are movable axially so as to move at least part of the needle out of the outer housing; a second position in which the inner housing has one or more radially flexible tags (7A) which are in communication with the barrel such that, in use, the plunger is movable axially into the barrel so as to expel medicament through the needle; and a third position in which one or more radially flexible tags (7A, 7B) on the inner housing are in communication with neither the plunger nor the barrel such that, in use, the plunger and barrel are able to retract in order to retract the needle into the outer housing.
Patent NZ-553573-A (NZ)
Title: A carton for bottles with an internal wall structure
Inventor: ARTIS KYM
IPC: B65D5/48
Filed: 2005-09-02
Abstract: A carton 12 suitable for transporting bottles, comprises a series of side wall panels that are interconnected and form an enclosure and can be manipulated from an empty collapsed orientation for storage in a space saving manner to an assembled orientation into which bottles can be loaded, and an internal wall structure positioned inside and connected to the side wall panels at pre-selected locations such that as the enclosure is manipulated from the collapsed orientation to the assembled orientation the internal wall structure is located in an operative position which defines separate compartments each adapted to receive a bottle and thereby avoid bottles loaded into the carton from contacting each other. The internal wall structure comprises a central divider 13 connected only to one of the side walls and lateral dividers 17a, 17b extending from the central divider 13. The central divider 13 includes two layers of material, and each lateral divider 17a, 17b is formed by a tongue cut into one of the layers and folded outward.
Patent NZ-563010-A (NZ)
Title: Method for the production of vacuum insulation panels
Inventor: KLASSEN JOHANN
IPC: E04B1/78
Filed: 2006-05-08
Abstract: A vacuum insulation panel and a process for its production are disclosed. The panel includes a shaped body of open-celled rigid foam which is packed into a gastight film, evacuated and welded shut so as to be airtight. The open-celled rigid polyurethane foam is compressed after curing and before evacuation.